After 12 weeks treatment, the reductions in HbA1c from baseline were 0.96% with 1.8mg MAR709, 0.9% with 1mg tirzepatide and 1.7% with 5mg tirzepatide
What are the safety considerations for both platforms
Side Effects of GLP-1 Agonists Common side effects may include Nausea Vomiting Diarrhea Loss of Appetite This occurs especially when starting the medication or increasing the dose
Glucagon increases energy use and fat burning
4,40 Insulin stimulation results in fatty acid synthesis in the adipose tissue, liver and lactating mammary glands, whilst simultaneously inhibiting lipolysis and fatty acid oxidation in the liver, skeletal muscle and adipose tissue
But Alexander, of Johns Hopkins Bloomberg School of Public Health, says you often have other options